Nick Page
Chief Operating Officer chez OXFORD BIOMEDICA PLC
Fortune : 153 407 $ au 31/03/2024
Profil
Nick Page is currently the Chief Operations Officer at Oxford Biomedica Plc.
Prior to this, he worked as the Head of Anti-Infectives at Novartis UK Ltd.
Mr. Page holds an MBA from The Open University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC
0,06% | 21/09/2023 | 60 417 ( 0,06% ) | 153 407 $ | 31/03/2024 |
Postes actifs de Nick Page
| Sociétés | Poste | Début |
|---|---|---|
| OXFORD BIOMEDICA PLC | Chief Operating Officer | 03/04/2019 |
Anciens postes connus de Nick Page
| Sociétés | Poste | Fin |
|---|---|---|
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Nick Page
| The Open University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
